A Phase 1, Randomized, Double Blind, Placebo and Active Controlled, Parallel Study to Evaluate the Effect of Repeat Doses of Isavuconazole on Cardiac Repolarization in Healthy Adult Subjects

Trial Profile

A Phase 1, Randomized, Double Blind, Placebo and Active Controlled, Parallel Study to Evaluate the Effect of Repeat Doses of Isavuconazole on Cardiac Repolarization in Healthy Adult Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 11 Jan 2017

At a glance

  • Drugs Isavuconazole (Primary) ; Moxifloxacin
  • Indications Aspergillosis; Candidiasis; Zygomycosis
  • Focus Adverse reactions
  • Sponsors Astellas Pharma
  • Most Recent Events

    • 11 Jan 2017 Results from NCT00412893 (post hoc analysis; n=257) and NCT01565720 (n=161) studies assessing effect of isavuconazole on cardiac repolarization, published in the Clinical Pharmacology and Therapeutics.
    • 29 Sep 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top